This is an unofficial archive of PsychonautWiki as of 2025-08-11T15:14:44Z. Content on this page may be outdated, incomplete, or inaccurate. Please refer to the original page for the most up-to-date information.
5-MAPB: Difference between revisions
>LockPicker m Revised german legal status |
>Raptorrr HCL salt potency described as 10% more potent when in fact it is roughly 36% more potent. |
||
| Line 7: | Line 7: | ||
This compound is known for its [[stimulating]], [[euphoria|euphoric]] and [[entactogen]]ic effects that is capable of acting a quasi-substitute for [[MDMA]] proper, which has resulted in its rise in popularity as a [[research chemical]] that is easily accessible through the use of online vendors. It has been sold as a [[designer drug]] since 2010.<ref>EMCDDA–Europol 2010 Annual Report on the implementation of Council Decision 2005/387/JHA | http://www.emcdda.europa.eu/publications/implementation-reports/2010</ref> | This compound is known for its [[stimulating]], [[euphoria|euphoric]] and [[entactogen]]ic effects that is capable of acting a quasi-substitute for [[MDMA]] proper, which has resulted in its rise in popularity as a [[research chemical]] that is easily accessible through the use of online vendors. It has been sold as a [[designer drug]] since 2010.<ref>EMCDDA–Europol 2010 Annual Report on the implementation of Council Decision 2005/387/JHA | http://www.emcdda.europa.eu/publications/implementation-reports/2010</ref> | ||
5-MAPB is commonly found as the succinate and hydrochloride salt. The hydrochloride salt is | 5-MAPB is commonly found as the succinate and hydrochloride salt. The hydrochloride salt is 36% more potent by mass so doses should be adjusted accordingly.{{citation needed}} | ||
==Chemistry== | ==Chemistry== | ||
| Line 67: | Line 67: | ||
{{#ask: [[Category:5-MAPB]][[Category:Experience]]|format=ul|Columns=1}} | {{#ask: [[Category:5-MAPB]][[Category:Experience]]|format=ul|Columns=1}} | ||
Additional experience reports can be found here: | Additional experience reports can be found here: | ||
* [https://www.erowid.org/experiences/subs/exp_5MAPB.shtml Erowid Experience Vaults: 5-MAPB] | |||
*[https://www.erowid.org/experiences/subs/exp_5MAPB.shtml Erowid Experience Vaults: 5-MAPB] | |||
==Toxicity and harm potential== | ==Toxicity and harm potential== | ||
| Line 88: | Line 89: | ||
{{DangerousInteractions/Intro}} | {{DangerousInteractions/Intro}} | ||
{{DangerousInteractions/Stimulants|self=5-MAPB}} | {{DangerousInteractions/Stimulants|self=5-MAPB}} | ||
{{DangerousInteractions/MAOI|nt=dopamine}} | {{DangerousInteractions/MAOI|nt=dopamine}} | ||
| Line 95: | Line 97: | ||
==Legal issues== | ==Legal issues== | ||
{{legalStub}} | {{legalStub}} | ||
*'''Germany''': 5-MAPB is controlled under the NpSG (New Psychoactive Substances Act)<ref>{{cite web|url=https://www.gesetze-im-internet.de/npsg/anlage.html|title=Anlage NpSG|publisher=Bundesministerium der Justiz und für Verbraucherschutz|access-date=December 18, 2019|language=de}}</ref> as of November 26, 2016.<ref>{{cite web|url=https://www.bgbl.de/xaver/bgbl/start.xav?startbk=Bundesanzeiger_BGBl&jumpTo=bgbl116s2615.pdf#__bgbl__%2F%2F*%5B%40attr_id%3D%27bgbl116s2615.pdf%27%5D__1576017393518|title=Gesetz zur Bekämpfung der Verbreitung neuer psychoaktiver Stoffe|publisher=Bundesanzeiger Verlag|access-date=December 18, 2019|language=de}}</ref> Production and import with the aim to place it on the market, administration to another person and trading is punishable. Possession is illegal but not penalized.<ref>{{cite web|url=https://www.gesetze-im-internet.de/npsg/__4.html|title=§ 4 NpSG|publisher=Bundesministerium der Justiz und für Verbraucherschutz|access-date=December 18, 2019|language=de}}</ref> | *'''Germany''': 5-MAPB is controlled under the NpSG (New Psychoactive Substances Act)<ref>{{cite web|url=https://www.gesetze-im-internet.de/npsg/anlage.html|title=Anlage NpSG|publisher=Bundesministerium der Justiz und für Verbraucherschutz|access-date=December 18, 2019|language=de}}</ref> as of November 26, 2016.<ref>{{cite web|url=https://www.bgbl.de/xaver/bgbl/start.xav?startbk=Bundesanzeiger_BGBl&jumpTo=bgbl116s2615.pdf#__bgbl__%2F%2F*%5B%40attr_id%3D%27bgbl116s2615.pdf%27%5D__1576017393518|title=Gesetz zur Bekämpfung der Verbreitung neuer psychoaktiver Stoffe|publisher=Bundesanzeiger Verlag|access-date=December 18, 2019|language=de}}</ref> Production and import with the aim to place it on the market, administration to another person and trading is punishable. Possession is illegal but not penalized.<ref>{{cite web|url=https://www.gesetze-im-internet.de/npsg/__4.html|title=§ 4 NpSG|publisher=Bundesministerium der Justiz und für Verbraucherschutz|access-date=December 18, 2019|language=de}}</ref> | ||
*'''United Kingdom''': 5-MAPB is a Class B drug. | *'''United Kingdom''': 5-MAPB is a Class B drug. | ||
| Line 100: | Line 103: | ||
==See also== | ==See also== | ||
*[[Responsible use]] | *[[Responsible use]] | ||
*[[Designer drug]] | *[[Designer drug]] | ||
| Line 111: | Line 115: | ||
==External links== | ==External links== | ||
*[https://en.wikipedia.org/wiki/5-MAPB 5-MAPB (Wikipedia)] | *[https://en.wikipedia.org/wiki/5-MAPB 5-MAPB (Wikipedia)] | ||
*[https://www.erowid.org/chemicals/5-mapb/ 5-MAPB (Erowid Vault)] | *[https://www.erowid.org/chemicals/5-mapb/ 5-MAPB (Erowid Vault)] | ||